Show Summary Details
Page of

Pulmonary thromboembolism 

Pulmonary thromboembolism
Pulmonary thromboembolism

Simone Wärntges

, Katrin Schäfer

, and Stavros V. Konstantinides

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 January 2022

Venous thromboembolism (VTE) is the third most frequent acute cardiovascular syndrome; its annual incidence may reach 1200 cases per 100,000 population aged ≥80 years. Besides age-related increases in predisposing conditions, the ageing process itself shifts the balance between pro and anticoagulant pathways towards a propensity to thrombosis. Evaluation of symptoms and clinical signs of suspected VTE in older adults should take into account ‘physiologic’ age-related cardiopulmonary changes. Using age-adjusted (in patients older than 50 years) D-dimer cut-off levels in combination with low or intermediate clinical probability increases the number of patients in whom PE can reliably be excluded without imaging tests. Age is a key determinant of the bleeding risk under fibrinolytic and anticoagulation treatment. Overall, the new oral anticoagulants are effective and safe in older adults; however, age-related changes in renal and other organ function and drug pharmacokinetics mandate regular monitoring and possible dose adjustments.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.